The hypothesis of this study is that esophageal and gastric dysmotility increase the risk of
developing aspiration-associated symptoms in children with neurologic impairment. The
investigators are conducting a ten week cross over study comparing prucalopride to famotidine
for the treatment of aspiration-associated symptoms.